XALUD THERAPEUTICS
Xalud Therapeutics is a biotech company that develops therapies for the treatment of neuro-inflammatory diseases. It offers a gene therapy platform that addresses chronic pain. The lead product candidate, XT-150 is in two P2 clinical studies for the treatment of Osteoarthritis Pain. Xalud is a portfolio company of PBM Capital Group. The company was established in 2009 and is based in San Francisco, California, United States.
XALUD THERAPEUTICS
Industry:
Biotechnology Health Care Medical Neuroscience Therapeutics
Founded:
2009-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.xaludthera.com
Total Employee:
11+
Status:
Active
Contact:
(434) 980-8105
Total Funding:
42.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Anteros Pharmaceuticals
Anteros Pharmaceuticals is a biotechnology company that develops drugs for fibrotic and other inflammatory diseases.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
PBM Capital Group
PBM Capital Group investment in Series C - Xalud Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-09 | Xalud Therapeutics Appoints Charles Triano as Chief Financial Officer |
Official Site Inspections
http://www.xaludthera.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Xalud Therapeutics"
WHO WE ARE - xaludthera.com
OUR MISSION . With leading efforts in neuropathic and osteoarthritic pain, we seek to transform the treatment of chronic inflammatory disease with a new gene therapy that uses a non-viral …See details»
Xalud Therapeutics Company Profile | Management and
[email protected]: Xalud Therapeutics Top Competitors. Company Employees Revenue Top technologies; Kolon TissueGene. 31: $7.5 M: Forbion. 21: $4.6 M: Amytrx Therapeutics. …See details»
Xalud Therapeutics, Inc. | LinkedIn
40 West 57th Street Suite 1810 New York , New York 10019, USSee details»
Xalud Therapeutics - Crunchbase Company Profile & Funding
Xalud Therapeutics is a biotech company that develops therapies for the treatment of neuro-inflammatory diseases. It offers a gene therapy platform that addresses chronic pain.See details»
Xalud Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Xalud Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 17 news, and 1 literature, Disease Domain:Nervous System Diseases, Immune …See details»
PATIENTS | Xalud - Xalud Therapeutics
For more information on the below studies, please visit ClinicalTrials.gov.. Osteoarthritis of the Knee . Title: Efficacy and Safety of XT-150 in Osteoarthritis of the Knee (NCT04124042)See details»
Xalud Therapeutics - PitchBook
Xalud Therapeutics General Information Description. Developer of a gene therapy platform designed to treat neuroinflammatory diseases. The company's platform creates therapies that …See details»
My Next Chapter with Xalud Therapeutics - LinkedIn
Jan 22, 2021 I am excited to build an incredible organization with unparalleled passion to offer a transformative medicine for patients in need. ... please visit our website at …See details»
Xalud Therapeutics Company Profile - Office Locations ... - Craft
Xalud Therapeutics $12.3 m in total funding,. See insights on Xalud Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Sarah Leblanc - director of regulatory and quality compliance at …
Organization Industry. biotechnology. Location. new york new york united states. Professional Background. Xalud Therapeutics, Inc. ... The website URL for xalud therapeutics, inc. is …See details»
Xalud Therapeutics appoints Dr. Diem Nguyen as CEO
Jan 22, 2021 – USA, NY – Xalud Therapeutics, a clinical-stage biotechnology company that has developed a non-viral gene therapy platform to treat pathologic inflammation through immune …See details»
CONTACT | Xalud - Xalud Therapeutics
Contact us at [email protected] to learn more. Careers At Xalud Therapeutics, we are driven to provide a patient-centric, scalable and easily administered treatment for chronic inflammatory …See details»
To Health: Xalud Therapeutics Is Bringing Gene Therapy to the …
Feb 8, 2023 The company’s name comes from the blending of the Spanish word for health (“salud”) and the letter “X,” referring to IL-10 as Xalud’s primary target.See details»
Xalud Therapeutics Receives FDA Fast Track Designation for XT
Dec 17, 2021 Xalud Therapeutics, a clinical-stage biotechnology company developing DNA delivery therapies using a non-viral platform, announced today that the United States Food …See details»
OUR PIPELINE - Xalud Therapeutics
There are over 300 million people around the globe who live with chronic inflammatory conditions. Patients living with unresolved Inflammation can have chronic, debilitating pain - pain that …See details»
Xalud Therapeutics Receives FDA Fast Track Designation for XT …
Dec 17, 2021 For more information, visit www.xaludthera.com. Contacts. Media Contact Carolyn Hawley Canale Communications [email protected] 619-849-5382 Contacts.See details»
OUR SCIENCE - Xalud Therapeutics
Cytokines are proteins that play a critical role in the inflammatory cascade that is part of the healing process. In response to an injury, the acute pro-inflammatory cytokine response lasts …See details»
Get control of chronic back pain with a full spectrum of therapy
Referencing World Health Organization guidelines published in late 2023, Findlay said treating chronic back pain requires a combination of education and rehabilitation.See details»
LATEST NEWS - Xalud Therapeutics
Mar 2, 2022 Xalud Therapeutics Doses First Patient in Phase 2a Trial of XT-150 for the Treatment of Facet Joint Osteoarthritis Pain . NEW YORK, March 2, 2022 – Xalud …See details»